The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of proton pump inhibitor (PPI) pharmacogenomics (PGx) on toxicities associated with immune checkpoint inhibitor (ICI) therapy.
 
Laura Kennedy
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Research Funding - Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Rajat Mohindra
Employment - Novartis (I); Roche
Stock and Other Ownership Interests - Novartis (I); Roche
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Novartis (I); Roche
 
Jessica Sharpe
No Relationships to Disclose
 
Sarah Mycroft
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Justin Balko
Stock and Other Ownership Interests - Beam Therapeutics; BioNano Genomics; crispr therapeutics
Consulting or Advisory Role - AstraZeneca; Lilly; Malinkrodt; Pfizer
Research Funding - Genentech/Roche; Incyte
Patents, Royalties, Other Intellectual Property - FCRL6 as an immunotherapy target; Patent on use of HLA-DR/MHC expression to predict response to immunotherapies
Other Relationship - NanoString Technologies
 
G Scott Chandler
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent pending as co-inventor of novel biomarker work performed as Roche employee
Travel, Accommodations, Expenses - Roche/Genentech
 
Svetlana Lyalina
Employment - Genentech
Stock and Other Ownership Interests - Roche